Link Mobility reported its Q4 2024 earnings, showcasing strong financial performance and strategic advancements. While the company did not provide specific earnings per share (EPS) or revenue data for ...

Ersodetug, a novel, fully human monoclonal antibody for the treatment of hyperinsulinism (HI), receives Breakthrough Therapy Designation and ...

Revenues, Gross Margin and EPS All Surpassed Guidance Range Issued on November 7, 2024Company Q1 2025 Guidance: Revenues to Decrease 8.5% ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...